Literature DB >> 23886772

Stressing HbF synthesis: role of translation?

Jane-Jane Chen1, Susan Perrine.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23886772      PMCID： PMC3724185          DOI： 10.1182/blood-2013-06-506139

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  The unfolded protein response: from stress pathway to homeostatic regulation.

Authors:  Peter Walter; David Ron
Journal:  Science       Date:  2011-11-25       Impact factor: 47.728

Review 2.  Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias.

Authors:  Jane-Jane Chen
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

3.  A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.

Authors:  Michael Boyce; Kevin F Bryant; Céline Jousse; Kai Long; Heather P Harding; Donalyn Scheuner; Randal J Kaufman; Dawei Ma; Donald M Coen; David Ron; Junying Yuan
Journal:  Science       Date:  2005-02-11       Impact factor: 47.728

4.  Heme-regulated eIF2α kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis.

Authors:  Rajasekhar N V S Suragani; Roshini S Zachariah; Jason G Velazquez; Sijin Liu; Chiao-Wang Sun; Tim M Townes; Jane-Jane Chen
Journal:  Blood       Date:  2012-04-12       Impact factor: 22.113

5.  Fetal globin gene inducers: novel agents and new potential.

Authors:  Susan P Perrine; Serguei A Castaneda; David H K Chui; Douglas V Faller; Ronald J Berenson; Noppadol Siritanaratku; Suthat Fucharoen
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

6.  Haem-regulated eIF2alpha kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency.

Authors:  Sijin Liu; Sanchita Bhattacharya; Anping Han; Rajasekhar N V S Suragani; Wanting Zhao; Rebecca C Fry; Jane-Jane Chen
Journal:  Br J Haematol       Date:  2008-07-28       Impact factor: 6.998

7.  Butyrate increases the efficiency of translation of gamma-globin mRNA.

Authors:  Rona S Weinberg; Xinjun Ji; Millicent Sutton; Susan Perrine; Yelena Galperin; Qiliang Li; Stephen A Liebhaber; George Stamatoyannopoulos; George F Atweh
Journal:  Blood       Date:  2004-10-12       Impact factor: 22.113

8.  Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.

Authors:  Rodwell Mabaera; Michael R Greene; Christine A Richardson; Sarah J Conine; Courtney D Kozul; Christopher H Lowrey
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

9.  Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism.

Authors:  Cynthia K Hahn; Christopher H Lowrey
Journal:  Blood       Date:  2013-05-20       Impact factor: 22.113
  9 in total
  5 in total

1.  δ-Aminolevulinate induces fetal hemoglobin expression by enhancing cellular heme biosynthesis.

Authors:  Li Liu; Xingguo Zhu; Alexander Yu; Christina M Ward; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-31

Review 2.  Therapeutic interventions to disrupt the protein synthetic machinery in melanoma.

Authors:  Gregory R Kardos; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2015-09       Impact factor: 4.693

Review 3.  Translational control by heme-regulated eIF2α kinase during erythropoiesis.

Authors:  Jane-Jane Chen
Journal:  Curr Opin Hematol       Date:  2014-05       Impact factor: 3.284

4.  Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms.

Authors:  Yan Dai; Jose Sangerman; Hong Yuan Luo; Suthat Fucharoen; David H K Chui; Douglas V Faller; Susan P Perrine
Journal:  Blood Cells Mol Dis       Date:  2015-10-27       Impact factor: 3.039

Review 5.  Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective.

Authors:  Rayan Bou-Fakhredin; Lucia De Franceschi; Irene Motta; Maria Domenica Cappellini; Ali T Taher
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.